Kiriş et al evaluated whether the change in mean platelet volume (MPV) predicts total mortality in 419 patients with non-ST-segment elevation myocardial infarction. 1 Measurements of MPV were performed at admission and after 24 hours. In multivariate analysis, DMPV was an independent predictor of total mortality. They concluded that an early increase in MPV after admission was independently associated with overall mortality in these patients.
Mean platelet volume can predict systemic inflammation and the thrombotic potential of the blood. 2 Larger platelets are known to be denser, and those platelets are associated with increased thrombogenesis in various cardiovascular diseases. [3] [4] [5] [6] [7] Platelets play an important role in the pathogenesis of acute coronary syndromes (ACSs). 8 A larger platelet volume is associated with enhanced platelet reactivity. 8 Automated cell counters are routinely available in many clinical laboratories and can be used to determine platelet count and the platelet volume indices, MPV, and platelet distribution width (PDW). The MPV is an independent predictor of impaired angiographic reperfusion and 6-month mortality among patients with STsegment elevation myocardial infarction (STEMI) treated with primary percutaneous coronary intervention (pPCI). 8, 9 We think that there are 2 important issues regarding MPV analysis in the Kiriş et al study. 1 First, MPV varies with time in EDTA-anticoagulated samples, and EDTA-induced platelet shape changes result in a progressive increase in MPV. 10 Variability in the amount of EDTA used in the sample has also been hypothesized as a cause for the fluctuation in MPV size. 11 The increase in MPV over time is demonstrated to be <0.5 fL if the samples are analyzed within 2 hours of venipuncture. Therefore, standardized EDTA tubes should be used, and the blood work of patients undergoing pPCI was processed within 10 minutes of sampling. Second, MPV has been extensively evaluated, but novel platelet indices such as PDW have been less well investigated as platelet activation markers. 12 Platelet activation indices focus on the fact that platelet activation causes morphologic changes, including spherical shape and pseudopodia formation. 13 Thus, platelets with increased number and size of pseudopodia differ in size, which will increase the PDW. 14 The PDW measures the variability in platelet size. In a recently published article, we demonstrated that a PDW value of 12.95 fL had a specificity of 64% and sensitivity of 60%; these are low values for a diagnostic potential of in-hospital major adverse cardiovascular events among patients with STEMI undergoing pPCI. 15 In multivariate analysis, PDW, MPV, high-sensitivity C-reactive protein, and glucose on admission were independent correlates of in-hospital major adverse cardiovascular events.
In conclusion, admission platelet indices such as MPV and PDW are simple, easily obtained correlates of platelet activation markers in patients with ACS. Although these indices may be used to predict short-and long-term prognosis following ACS, one should keep in mind the potential analytical limitations of those platelet indices.
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